The evidence on the effectiveness of management for malignant pleural effusion: a systematic review

European Journal of Cardio-thoracic Surgery

Volumn 29, Issue 5, 2006, Pages 829-838

  Tan, Carol ^a   Sedrakyan, Artyom ^b   Browne, John ^c,d   Swift, Simon ^a   Treasure, Tom ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^c ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Malignant effusion; Pleurodesis; VATS

Indexed keywords

ANTIINFECTIVE AGENT; BLEOMYCIN; CHLORMETHINE; DOXORUBICIN; DOXYCYCLINE; FIBRIN GLUE; IMMUNOMODULATING AGENT; INTERFERON; MEPACRINE; MITOXANTRONE; PREDNISOLONE; SCLEROSING AGENT; TALC; TETRACYCLINE; THIOTEPA;

AERATION; CANCER RECURRENCE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA BASE; DECORTICATION; DEVICE; DRAIN; EMBASE; EVALUATION; HUMAN; LANGUAGE; MEDLINE; METHODOLOGY; PLEURA EFFUSION; PLEURECTOMY; PLEURODESIS; PRIORITY JOURNAL; RANDOMIZATION; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SURGICAL PATIENT; SYSTEMATIC REVIEW; THORACOSCOPY; TREATMENT OUTCOME; TUBE;

CHEST TUBES; DRAINAGE; HUMANS; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; RANDOMIZED CONTROLLED TRIALS; TALC; THORACIC SURGERY, VIDEO-ASSISTED;

EID: 33646117043     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2005.12.025     Document Type: Review

References (73)

1. Walker-Renard P.B., Vaughan L.M., and Sahn S.A. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 120 (1994) 56-64
2. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 2004, CD002916.
3. Maskell N.A., and Butland R.J. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 58 Suppl. 2 (2003) ii8-ii17
4. Antunes G., Neville E., Duffy J., and Ali N. BTS guidelines for the management of malignant pleural effusions. Thorax 58 Suppl. 2 (2003) ii29-ii38
5. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., and McQuay H.J. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
6. Sorensen P.G., Svendsen T.L., and Enk B. Treatment of malignant pleural effusion with drainage, with and without instillation of talc. Eur J Respir Dis 65 (1984) 131-135
7. Putnam Jr. J.B., Light R.W., Rodriguez R.M., Ponn R., Olak J., Pollak J.S., Lee R.B., Payne D.K., Graeber G., and Kovitz K.L. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 86 (1999) 1992-1999
8. Groth G., Gatzemeier U., Haussingen K., Heckmayr M., Magnussen H., Neuhauss R., and Pavel J.V. Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Ann Oncol 2 (1991) 213-215
9. North S.A., Au H.J., Halls S.B., Tkachuk L., and Mackey J.R. A randomized, phase III, double-blind, placebo-controlled trial of intrapleural instillation of methylprednisolone acetate in the management of malignant pleural effusion. Chest 123 (2003) 822-827
10. Zaloznik A.J., Oswald S.G., and Langin M. Intrapleural tetracycline in malignant pleural effusions. A randomized study. Cancer 51 (1983) 752-755
11. Mejer J., Mortensen K.M., and Hansen H.H. Mepacrine hydrochloride in the treatment of malignant pleural effusion. A controlled randomized trial. Scand J Respir Dis 58 (1977) 319-323
12. Leverenz A., Heckmayr M., Tischer-Neuhauss R., and Gatzemeier U. Intrapleural palliative treatment of malignant pleural effusions with talcum versus placebo (pleural tube alone). Lung Cancer 29A (2000) 274
13. Hamed H., Fentiman I.S., Chaudary M.A., and Rubens R.D. Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast. Br J Surg 76 (1989) 1266-1267
14. Lynch T., Kalish L., Mentzer S.J., Decamp M., Strauss G., and Sugarbaker D.J. Optimal therapy of malignant pleural effusions: report of a randomised trial of bleomycin, tetracycline, and talc and a meta-analysis. Int J Oncol 8 (1996) 183-190
15. Noppen M., Degreve J., Mignolet M., and Vincken W. A prospective, randomised study comparing the efficacy of talc slurry and bleomycin in the treatment of malignant pleural effusions. Acta Clin Belg 52 (1997) 258-262
16. Zimmer P.W., Hill M., Casey K., Harvey E., and Low D.E. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest 112 (1997) 430-434
17. Diacon A.H., Wyser C., Bolliger C.T., Tamm M., Pless M., Perruchoud A.P., and Soler M. Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions. Am J Respir Crit Care Med 162 (2000) 1445-1449
18. Ong K.C., Indumathi V., Raghuram J., and Ong Y.Y. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions. Respirology 5 (2000) 99-103
19. Haddad F.J., Younes R.N., Gross J.L., and Deheinzelin D. Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial. World J Surg 28 (2004) 749-753
20. Fentiman I.S., Rubens R.D., and Hayward J.L. A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. Eur J Cancer Clin Oncol 22 (1986) 1079-1081
21. Fentiman I.S., Rubens R.D., and Hayward J.L. Control of pleural effusions in patients with breast cancer. A randomized trial. Cancer 52 (1983) 737-739
22. Emad A., and Rezaian G.R. Treatment of malignant pleural effusions with a combination of bleomycin and tetracycline. A comparison of bleomycin or tetracycline alone versus a combination of bleomycin and tetracycline. Cancer 78 (1996) 2498-2501
23. Kessinger A., and Wigton R.S. Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study. J Surg Oncol 36 (1987) 81-83
24. Martinez-Moragon E., Aparicio J., Rogado M.C., Sanchis J., Sanchis F., and Gil-Suay V. Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin. Eur Respir J 10 (1997) 2380-2383
25. Patz Jr. E.F., McAdams H.P., Erasmus J.J., Goodman P.C., Culhane D.K., Gilkeson R.C., and Herndon J. Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. Chest 113 (1998) 1305-1311
26. Ruckdeschel J.C., Moores D., Lee J.Y., Einhorn L.H., Mandelbaum I., Koeller J., Weiss G.R., Losada M., and Keller J.H. Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest 100 (1991) 1528-1535
27. Won S.O., Choi J., Yong S.K., Yong H.D., Tae W.J., and Mann H.J. Intrapleural doxycycline and bleomycin in the management of malignant pleural effusions: a randomised study. Tuberc Respir Dis 44 (1997) 85-92
28. Leahy B.C., Honeybourne D., Brear S.G., Carroll K.B., Thatcher N., and Stretton T.B. Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline. Eur J Respir Dis 66 (1985) 50-54
29. Salomaa E.R., Pulkki K., and Helenius H. Pleurodesis with doxycycline or Corynebacterium parvum in malignant pleural effusion. Acta Oncol 34 (1995) 117-121
30. Bayly T.C., Kisner D.L., Sybert A., Macdonald J.S., Tsou E., and Schein P.S. Tetracycline and quinacrine in the control of malignant pleural effusions. A randomized trial. Cancer 41 (1978) 1188-1192
31. Gust R., Kleine P., and Fabel H. Fibrin glue and tetracycline pleurodesis in recurrent malignant pleural effusions. A randomized comparative study. Med Klin 85 (1990) 18-23
32. Loutsidis A., Bellenis I., Argiriou M., and Exarchos N. Tetracycline compared with mechlorethamine in the treatment of malignant pleural effusions. A randomized trial. Respir Med 88 (1994) 523-526
33. Tattersall M., Fox R., Woods R., and Kefford R. Intracavitary adriamycin nitrogen mustard and tetracycline in the control of malignant effusions: a randomised study. Med J Aust 2 (1980) 447-448
34. Koldsland S., Svennevig J.L., Lehne G., and Johnson E. Chemical pleurodesis in malignant pleural effusions: a randomised prospective study of mepacrine versus bleomycin. Thorax 48 (1993) 790-793
35. Schmidt M., Schaarschmidt G., and Chemaissani A. Pleurodesis in malignant pleural effusion: bleomycin vs. mitoxantrone. Pneumologie 51 (1997) 367-372
36. Sartori S., Trevisani L., Nielsen I., Tassinari D., and Abbasciano V. Intracavitary bleomycin vs interferon in the management of malignant pleural effusions. Chest 113 (1998) 1145-1146
37. Hillerdal G., Kiviloog J., Nou E., and Steinholtz L. Corynebacterium parvum in malignant pleural effusion. A randomized prospective study. Eur J Respir Dis 69 (1986) 204-206
38. Ostrowski M.J., Priestman T.J., Houston R.F., and Martin W.M. A randomized trial of intracavitary bleomycin and Corynebacterium parvum in the control of malignant pleural effusions. Radiother Oncol 14 (1989) 19-26
39. Luh K.T., Yang P.C., Kuo S.H., Chang D.B., Yu C.J., and Lee L.N. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. Cancer 69 (1992) 674-679
40. Nio Y., Nagami H., Tamura K., Tsubono M., Nio M., Sato M., Kawabata K., Hayashi H., Shiraishi T., Imai S., Tsuchitani T., Mizuta J., Nakagawa M., and Fukumoto M. Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion. Br J Cancer 80 (1999) 775-785
41. Masuno T., Kishimoto S., Ogura T., Honma T., Niitani H., Fukuoka M., and Ogawa N. A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer. Cancer 68 (1991) 1495-1500
42. Bo H., and Yaohua W. Curative effect of highly agglutinative staphylococcin plus cisplatin in treatment of malignant pleural effusion and ascites. Chinese J Clin Oncol 25 (1998) 623-624
43. Bjermer L., Gruber A., Sue-Chu M., Sandstrom T., Eksborg S., and Henriksson R. Effects of intrapleural mitoxantrone and mepacrine on malignant pleural effusion-a randomised study. Eur J Cancer 31A (1995) 2203-2208
44. Manes N., Rodriguez-Panadero F., Bravo J.L., Hernandez H., and Alix A. Talc pleurodesis. Prospective and randomised study. Clinical follow-up. Chest 118 4 (2000) 131S
45. Yim A.P., Chan A.T., Lee T.W., Wan I.Y., and Ho J.K. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 62 (1996) 1655-1658
46. Evans T.R., Stein R.C., Pepper J.R., Gazet J.C., Ford H.T., and Coombes R.C. A randomised prospective trial of surgical against medical tetracycline pleurodesis in the management of malignant pleural effusions secondary to breast cancer. Eur J Cancer 29A (1993) 316-319
47. Dryzer S.R., Allen M.L., Strange C., and Sahn S.A. A comparison of rotation and nonrotation in tetracycline pleurodesis. Chest 104 (1993) 1763-1766
48. Mager H.J., Maesen B., Verzijlbergen F., and Schramel F. Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis. Lung Cancer 36 (2002) 77-81
49. Villanueva A.G., Gray Jr. A.W., Shahian D.M., Williamson W.A., and Beamis Jr. J.F. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 49 (1994) 23-25
50. Davies C.W.H., Chapman S., Reza T., and Thomas J. Efficacy of short (24 h) versus longer (72 h) chest drainage after talc pleurodesis for malignant pleural effusion. Eur Respir J 22 Suppl. 45 (2003) 192s
51. Clementsen P., Evald T., Grode G., Hansen M., Krag J.G., and Faurschou P. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir Med 92 (1998) 593-596
52. Fry W.A., and Khandekar J.D. Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol 2 (1995) 160-164
53. Harvey J.C., Erdman C.B., and Beattie E.J. Early experience with videothoracoscopic hydrodissection pleurectomy in the treatment of malignant pleural effusion. J Surg Oncol 59 (1995) 243-245
54. Martini N., Bains M.S., and Beattie Jr. E.J. Indications for pleurectomy in malignant effusion. Cancer 35 (1975) 734-738
55. Waller D.A., Morritt G.N., and Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest 107 (1995) 1454-1456
56. Soysal O., Karaoglanoglu N., Demiracan S., Topcu S., Tastepe I., Kaya S., Unlu M., and Cetin G. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg 11 (1997) 210-213
57. Genc O., Petrou M., Ladas G., and Goldstraw P. The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions. Eur J Cardiothorac Surg 18 (2000) 143-146
58. Petrou M., Kaplan D., and Goldstraw P. Management of recurrent malignant pleural effusions. The complementary role talc pleurodesis and pleuroperitoneal shunting. Cancer 75 (1995) 801-805
59. Reich H., Beattie E.J., and Harvey J.C. Pleuroperitoneal shunt for malignant pleural effusions: a one-year experience. Semin Surg Oncol 9 (1993) 160-162
60. Schulze M., Boehle A.S., Kurdow R., Dohrmann P., and Henne-Bruns D. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg 71 (2001) 1809-1812
61. Ferrer J., Villarino M.A., Tura J.M., Traveria A., and Light R.W. Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest 119 (2001) 1901-1905
62. Chen Y.M., Shih J.F., Yang K.Y., Lee Y.C., and Perng R.P. Usefulness of pig-tail catheter for palliative drainage of malignant pleural effusions in cancer patients. Support Care Cancer 8 (2000) 423-426
63. Parulekar W., Di Primio G., Matzinger F., Dennie C., and Bociek G. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions. Chest 120 (2001) 19-25
64. Pien G.W., Gant M.J., Washam C.L., and Sterman D.H. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest 119 (2001) 1641-1646
65. Pollak J.S., Burdge C.M., Rosenblatt M., Houston J.P., Hwu W.J., and Murren J. Treatment of malignant pleural effusions with tunneled long-term drainage catheters. J Vasc Interv Radiol 12 (2001) 201-208
66. Putnam Jr. J.B., Walsh G.L., Swisher S.G., Roth J.A., Suell D.M., Vaporciyan A.A., Smythe W.R., Merriman K.W., and DeFord L.L. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 69 (2000) 369-375
67. Smart J.M., and Tung K.T. Initial experiences with a long-term indwelling tunnelled pleural catheter for the management of malignant pleural effusion. Clin Radiol 55 (2000) 882-884
68. Morrison M.C., Mueller P.R., Lee M.J., Saini S., Brink J.A., Dawson S.L., Cortell E.D., and Hahn P.F. Sclerotherapy of malignant pleural effusion through sonographically placed small-bore catheters. Am J Roentgenol 158 (1992) 41-43
69. Seaton K.G., Patz Jr. E.F., and Goodman P.C. Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy. Am J Roentgenol 164 (1995) 589-591
70. Vazquez-Pelillo J.C., Pena G.E., Leon A.P., Garcia F.E., de Alvaro L.J., and Folque G.E. Malignant pleural effusions: a description of an alternative method of external drainage with a fine-caliber catheter. Arch Bronconeumol 33 (1997) 450-452
71. Boland G.W., Gazelle G.S., Girard M.J., and Mueller P.R. Asymptomatic hydropneumothorax after therapeutic thoracentesis for malignant pleural effusions. Am J Roentgenol 170 (1998) 943-946
72. Chang Y.C., Patz Jr. E.F., and Goodman P.C. Pneumothorax after small-bore catheter placement for malignant pleural effusions. Am J Roentgenol 166 (1996) 1049-1051
73. Dresler C.M., Olak J., Herndon J.E., Richards W.G., Scalzetti E., Fleishmann S.B., Hernstine K.H., Demmy T., Jablons D.M., Kohman L., Daniel T.M., Haasler G.B., and Sugarbaker D.J. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 127 (2005) 909-915